The Hartford Insurance Group, Inc.
HIG
$136.36
-0.32%
The Hartford Insurance Group, Inc. is a diversified insurance and financial services company providing property and casualty insurance, group benefits, and mutual funds, operating primarily in the United States. As a well-established player in the insurance industry, it is recognized for its service excellence and strong brand trust, competing alongside major insurers like Chubb and Travelers. The current investor narrative centers on its robust underwriting discipline and capital return program, though recent commentary from Zacks suggests that while the company remains a solid hold, its growth is moderate relative to peers, prompting debates about its ability to sustain margin expansion in a competitive pricing environment.…
HIG
The Hartford Insurance Group, Inc.
$136.36
Related headlines
Investment Opinion: Should I buy HIG Today?
Based on the analysis, HIG is rated as a Hold. The stock offers a reasonable risk/reward with an 8.3% upside to the average analyst target, but lacks catalysts for significant re-rating. The thesis is that HIG is a well-managed insurer with stable earnings, but its moderate growth limits upside potential.
Sign up to view all
HIG 12-Month Price Forecast
The AI model assesses HIG as neutral, reflecting a balanced risk/reward profile. The stock's low valuation provides a margin of safety, but the lack of growth catalysts limits upside. The stance would upgrade to bullish if revenue growth accelerates above 10% or if the PE expands toward the industry average. Conversely, a downgrade to bearish would occur if underwriting results deteriorate or if the stock breaks below its 52-week low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Hartford Insurance Group, Inc.'s 12-month outlook, with a consensus price target around $149.85 and implied upside of +9.9% versus the current price.
Average Target
$149.85
0 analysts
Implied Upside
+9.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$135 - $164
Analyst target range
Analyst coverage is robust with 20 analysts providing ratings, though the consensus recommendation is 'none' indicating a lack of clear consensus. The average target price is $149.85, implying an upside of approximately 8.3% from the current price of $138.37. The distribution of ratings is not provided, but recent actions from firms like Piper Sandler (downgrade to Neutral) and Evercore ISI (In Line) suggest a cautious tone, while others like Wells Fargo and Mizuho maintain Overweight/Outperform ratings, indicating a mixed sentiment. The target price range spans from $135.00 (low) to $164.00 (high), with the low target suggesting a potential downside of -2.4% and the high target implying a significant upside of 18.5%. The wide spread of $29 between low and high targets indicates considerable uncertainty about the company's future performance, likely due to varying views on underwriting cycles and investment income. The high target likely assumes continued margin expansion and strong capital returns, while the low target may factor in potential catastrophe losses or competitive pressures. Recent downgrades by Piper Sandler and the neutral stance from Evercore ISI could signal a shift in sentiment, but the overall average target still suggests a positive outlook.
Drowning in data?
Find the real signal!
Bulls vs Bears: HIG Investment Factors
HIG presents a mixed picture: strong profitability and attractive valuation are offset by moderate growth and mixed analyst sentiment. The bull case is supported by a 36% net income surge and a low PE, while the bear case highlights sluggish revenue growth and underperformance relative to the market. Currently, the evidence slightly favors the bull side due to compelling valuation and solid earnings, but the key tension is whether the company can accelerate growth to justify a re-rating. If revenue growth remains in the single digits, the stock may stay range-bound, but any acceleration could unlock significant upside.
Bullish
- Strong Earnings Growth: Q1 2026 net income surged 36% YoY to $856M from $630M, with EPS rising to $3.08 from $2.18. This demonstrates robust underwriting and operational efficiency, outpacing revenue growth.
- Attractive Valuation: Trailing PE of 10.2x is 32% below the industry average of 15x, and PEG ratio of 0.36 suggests undervaluation relative to growth. The stock trades at a discount to peers despite solid profitability.
- Solid Capital Returns: With a dividend yield of 1.58% and a payout ratio of only 16%, there is ample room for dividend increases and buybacks. The company has a history of returning capital to shareholders.
- Low Financial Risk: Debt-to-equity ratio of 0.23 and current ratio of 17.65 indicate a strong balance sheet with minimal leverage. This provides stability and flexibility in adverse scenarios.
Bearish
- Moderate Revenue Growth: Revenue grew only 6.1% YoY in Q1 2026, and 1-year price change is just +2.7%, underperforming the S&P 500's +18.7%. This indicates limited growth prospects relative to broader market.
- Mixed Analyst Ratings: Recent downgrades by Piper Sandler to Neutral and Evercore ISI to In Line reflect cautious sentiment. The consensus recommendation is 'none', indicating a lack of strong conviction among analysts.
- Margin Volatility: Gross margin fluctuated from 41.3% in Q1 2025 to 49.5% in Q4 2025, then down to 44.7% in Q1 2026. This inconsistency raises concerns about underwriting discipline and cost control.
- Underperformance vs Market: Relative strength over 1 year is -15.9% and over 6 months is -15.2%, showing significant underperformance. This suggests investors are favoring other sectors or companies.
HIG Technical Analysis
The stock is currently in a range-bound consolidation phase, with a 1-year price change of +2.72% indicating a lack of strong directional trend. Trading at $138.37, the stock sits at approximately 82% of its 52-week range (low of $120.33, high of $146.07), suggesting it is closer to the higher end but not at extremes, reflecting a neutral to slightly positive sentiment. The 6-month price change of -0.63% further confirms the sideways movement, with the stock oscillating between support and resistance levels without a clear breakout.
Beta
0.45
0.45x market volatility
Max Drawdown
-12.3%
Largest decline past year
52-Week Range
$120-$146
Price range past year
Annual Return
+2.4%
Cumulative gain past year
| Period | HIG Return | S&P 500 |
|---|---|---|
| 1m | -0.8% | -1.1% |
| 3m | +5.2% | +3.0% |
| 6m | +2.6% | +15.4% |
| 1y | +2.4% | +16.2% |
| ytd | -0.5% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HIG Fundamental Analysis
Revenue growth has been steady, with the most recent quarter (Q1 2026) showing revenue of $7.226 billion, a 6.1% year-over-year increase from $6.81 billion in Q1 2025. This growth is consistent with the prior quarters, as Q4 2025 revenue was $7.312 billion and Q3 2025 was $7.232 billion, indicating a stable trajectory rather than acceleration. The company's net income for Q1 2026 was $856 million, up from $630 million in the year-ago quarter, reflecting improved profitability. Gross margin for Q1 2026 was 44.67%, which is lower than the 48.95% in Q4 2025 but higher than the 41.26% in Q1 2025, showing some quarterly volatility but an overall improving trend.
Quarterly Revenue
$7.2B
2026-03
Revenue YoY Growth
+6.1%
YoY Comparison
Gross Margin
44.7%
Latest Quarter
Free Cash Flow
$5.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HIG Overvalued?
Given that net income is positive, the PE ratio is the primary valuation metric. The trailing PE is 10.20x, while the forward PE is 10.11x, indicating that the market expects stable earnings with minimal growth, as the gap between trailing and forward is negligible. This suggests that the market is not pricing in significant earnings expansion, which is consistent with the moderate growth narrative. Compared to the industry average PE of 15x (based on typical insurance sector multiples), HIG trades at a discount of approximately 32%, which could be justified by its lower growth prospects relative to some peers. Historically, the stock's PE has ranged from 6.1x to 14.9x over the past five years, with the current 10.2x sitting near the middle of that range, suggesting that the stock is fairly valued relative to its own history.
PE
10.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 6x~15x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are moderate, given a debt-to-equity ratio of 0.23 and a current ratio of 17.65, indicating a strong balance sheet. However, the company's net margin of 13.6% is susceptible to underwriting cycles and catastrophe losses, as seen in Q1 2025 when net income dropped to $630M. The payout ratio of 16% provides a cushion, but a prolonged soft market could pressure earnings and force dividend cuts. Free cash flow of $5.82B TTM is robust, but reliance on investment income exposes the company to interest rate fluctuations.
FAQ
Key risks include: (1) underwriting losses from natural catastrophes, which could significantly impact earnings, as seen in Q1 2025 when net income dropped to $630M; (2) competitive pricing pressure in the insurance market, which could compress margins; (3) interest rate fluctuations affecting investment income, a major revenue source; and (4) the stock's underperformance relative to the market, with a 1-year relative strength of -15.9%, indicating potential continued weakness. The most severe risk is a major catastrophe combined with a soft pricing cycle, which could drive the stock to its 52-week low of $120.33, a -13% downside.
The 12-month forecast is moderately positive, with a base case probability of 55% targeting $140-$150, aligning with the average analyst target of $149.85. The bull case (25% probability) could reach $150-$164 if earnings surprise positively, while the bear case (20% probability) might see $120-$135 if underwriting deteriorates. The most likely scenario is the base case, assuming steady growth and stable margins. Investors should monitor quarterly earnings for signs of margin expansion or contraction.
HIG appears undervalued relative to its industry, trading at a PE of 10.2x versus the industry average of 15x, a 32% discount. Its PEG ratio of 0.36 also suggests undervaluation given its earnings growth. Historically, the stock's PE has ranged from 6.1x to 14.9x, and the current level is near the middle, indicating fair value relative to its own history. The market is pricing in stable but unexciting growth, which is consistent with the company's moderate revenue expansion.
HIG is a reasonable buy for value investors seeking a stable insurance company with a low PE of 10.2x and a dividend yield of 1.6%. The average analyst target of $149.85 implies 8.3% upside, but the low target of $135 suggests downside risk. It is a good buy if you are comfortable with moderate growth and are looking for a defensive stock with strong capital returns. However, for growth-oriented investors, the limited upside may not be compelling.
HIG is more suitable for long-term investment due to its stable earnings, low beta of 0.45, and consistent dividend payments. Short-term trading is less attractive given the stock's range-bound behavior and lack of volatility. A minimum holding period of 3-5 years is recommended to benefit from capital appreciation and dividend compounding. The company's strong balance sheet and capital return program make it a reliable long-term holding for income-focused investors.